These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 32457107)

  • 1. KPC-50 Confers Resistance to Ceftazidime-Avibactam Associated with Reduced Carbapenemase Activity.
    Poirel L; Vuillemin X; Juhas M; Masseron A; Bechtel-Grosch U; Tiziani S; Mancini S; Nordmann P
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32457107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a KPC-84 harboring Klebsiella pneumoniae ST11 clinical isolate with ceftazidime-avibactam resistance.
    Gong Y; Feng Y; Zong Z; Lv X
    Eur J Clin Microbiol Infect Dis; 2024 Oct; 43(10):2029-2035. PubMed ID: 39110337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KPC-39-Mediated Resistance to Ceftazidime-Avibactam in a Klebsiella pneumoniae ST307 Clinical Isolate.
    Jousset AB; Oueslati S; Emeraud C; Bonnin RA; Dortet L; Iorga BI; Naas T
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0116021. PubMed ID: 34606331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a KPC Variant Conferring Resistance to Ceftazidime-Avibactam from ST11 Carbapenem-Resistant
    Wu Y; Yang X; Liu C; Zhang Y; Cheung YC; Wai Chi Chan E; Chen S; Zhang R
    Microbiol Spectr; 2022 Apr; 10(2):e0265521. PubMed ID: 35416703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam.
    Galani I; Antoniadou A; Karaiskos I; Kontopoulou K; Giamarellou H; Souli M
    Clin Microbiol Infect; 2019 Jun; 25(6):763.e5-763.e8. PubMed ID: 30928562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KPC-53, a KPC-3 Variant of Clinical Origin Associated with Reduced Susceptibility to Ceftazidime-Avibactam.
    Di Pilato V; Aiezza N; Viaggi V; Antonelli A; Principe L; Giani T; Luzzaro F; Rossolini GM
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33106265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KPC-85, a carbapenemase-producing and ceftazidime-avibactam-resistant KPC-3 variant found in Klebsiella pneumoniae ST512 in the Netherlands.
    Jamin C; Notermans DW; Beuken E; Maat I; Lansu S; Witteveen S; Landman F; van Alphen L; Oteo-Iglesias J; Carattoli A; Hendrickx APA;
    Int J Antimicrob Agents; 2024 Sep; 64(3):107271. PubMed ID: 39002702
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular Mechanisms Driving the
    Li X; Ke H; Wu W; Tu Y; Zhou H; Yu Y
    mSphere; 2021 Dec; 6(6):e0085921. PubMed ID: 34935448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Klebsiella pneumoniae carbapenemase (KPC) producer resistant to ceftazidime-avibactam due to a deletion in the blaKPC3 gene.
    Antinori E; Unali I; Bertoncelli A; Mazzariol A
    Clin Microbiol Infect; 2020 Jul; 26(7):946.e1-946.e3. PubMed ID: 32061796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne
    Shields RK; Chen L; Cheng S; Chavda KD; Press EG; Snyder A; Pandey R; Doi Y; Kreiswirth BN; Nguyen MH; Clancy CJ
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo bactericidal activity of ceftazidime-avibactam against Carbapenemase-producing
    Zhang W; Guo Y; Li J; Zhang Y; Yang Y; Dong D; Zhu D; He P; Hu F
    Antimicrob Resist Infect Control; 2018; 7():142. PubMed ID: 30479755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of a Ceftazidime-Avibactam-Resistant
    Shen S; Shi Q; Han R; Guo Y; Yang Y; Wu S; Yin D; Hu F
    Microbiol Spectr; 2022 Feb; 10(1):e0184021. PubMed ID: 35080422
    [No Abstract]   [Full Text] [Related]  

  • 13. KPC Beta-Lactamases Are Permissive to Insertions and Deletions Conferring Substrate Spectrum Modifications and Resistance to Ceftazidime-Avibactam.
    Hobson CA; Bonacorsi S; Jacquier H; Choudhury A; Magnan M; Cointe A; Bercot B; Tenaillon O; Birgy A
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 33020157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms responsible KPC-135-mediated resistance to ceftazidime-avibactam in ST11-K47 hypervirulent
    Shi Q; Shen S; Tang C; Ding L; Guo Y; Yang Y; Wu S; Han R; Yin D; Hu F
    Emerg Microbes Infect; 2024 Dec; 13(1):2361007. PubMed ID: 38801099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Ceftazidime-Avibactam-Resistant and Carbapenem-Susceptible Klebsiella pneumoniae Strain Harboring
    Niu S; Chavda KD; Wei J; Zou C; Marshall SH; Dhawan P; Wang D; Bonomo RA; Kreiswirth BN; Chen L
    mSphere; 2020 Aug; 5(4):. PubMed ID: 32848008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-to-Patient Transmission of Klebsiella pneumoniae Carbapenemase Variants with Reduced Ceftazidime-Avibactam Susceptibility.
    Munoz-Price LS; Reeme AE; Buchan BW; Mettus RT; Mustapha MM; Van Tyne D; Shields RK; Doi Y
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and genotypic analysis of KPC-51 and KPC-52, two novel KPC-2 variants conferring resistance to ceftazidime/avibactam in the KPC-producing Klebsiella pneumoniae ST11 clone background.
    Sun L; Chen W; Li H; Li L; Zou X; Zhao J; Lu B; Li B; Wang C; Li H; Liu Y; Cao B
    J Antimicrob Chemother; 2020 Oct; 75(10):3072-3074. PubMed ID: 32719857
    [No Abstract]   [Full Text] [Related]  

  • 18. Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview.
    Hobson CA; Pierrat G; Tenaillon O; Bonacorsi S; Bercot B; Jaouen E; Jacquier H; Birgy A
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0044722. PubMed ID: 35980232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo.
    Göttig S; Frank D; Mungo E; Nolte A; Hogardt M; Besier S; Wichelhaus TA
    J Antimicrob Chemother; 2019 Nov; 74(11):3211-3216. PubMed ID: 31365094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo emergence of cefiderocol and ceftazidime/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime/avibactam -based therapies.
    Amadesi S; Amedeo A; Rinaldi M; Palombo M; Giannella M; Gaibani P
    Diagn Microbiol Infect Dis; 2024 Sep; 110(1):116372. PubMed ID: 38875893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.